Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop …,

The clinical study in diabetes together with the joint venture’s initial focus on CIPN enables the evaluation of ricolinostat in two peripheral neuropathy …, The clinical study in diabetes together with the joint venture’s initial focus on CIPN enables the evaluation of ricolinostat in two peripheral neuropathy …, Read More

Scroll to Top